For the year ending 2026-01-30, SAIC had $126M increase in cash & cash equivalents over the period. $577M in free cash flow.
| Cash Flow | 2026-01-30 |
|---|---|
| Net income | 358 |
| Depreciation and amortization | 149 |
| Deferred income taxes | 81 |
| Stock-based compensation expense | 64 |
| Gain on divestitures | 0 |
| Other | -1 |
| Receivables | -161 |
| Prepaid expenses and other current assets | 44 |
| Accounts payable and other accrued liabilities | -101 |
| Accrued payroll and employee benefits | -28 |
| Operating lease assets and liabilities, net | -2 |
| Other assets and other long-term liabilities, net | -30 |
| Net cash provided by operating activities | 609 |
| Cash paid for acquisition, net of cash acquired | 203 |
| Expenditures for property, plant, and equipment | 32 |
| Contributions to investments | 11 |
| Purchases of marketable securities | 9 |
| Sales of marketable securities | 7 |
| Proceeds from sale of equity method investments | 0 |
| Proceeds from divestitures | 0 |
| Cash divested upon deconsolidation of joint venture | 0 |
| Other | 0 |
| Net cash (used in) provided by investing activities | -248 |
| Proceeds from borrowings | 2,745 |
| Principal payments on borrowings | 2,474 |
| Stock repurchased and retired or withheld for taxes on equity awards | 445 |
| Dividend payments to stockholders | 70 |
| Issuances of stock | 22 |
| Debt issuance costs | 9 |
| Other | -4 |
| Net cash used in financing activities | -235 |
| Net increase (decrease) in cash, cash equivalents and restricted cash | 126 |
| Cash, cash equivalents and restricted cash at beginning of period | 64 |
| Cash, cash equivalents and restricted cash at end of period | 190 |
Science Applications International Corp (SAIC)
Science Applications International Corp (SAIC)